A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...
MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR-T cell therapy program for autoimmune diseases.
Treatments are the same as cancer sufferers but they don't receive the same support, a mother says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback